George A. Fisher

Also affiliated with Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)”.

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of Clinical Oncology(2022)10.1200/jco.22.01013

N/A

4.9DataRank · unranked

297 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +14 more

Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study

The Lancet. Gastroenterology & hepatology(2020)10.1016/s2468-1253(20)30088-1

N/A

3.2DataRank · unranked

101 citations

Nynke S. van den Berg, Brock A. Martin, Naoki Nishio, Zachary Hart, Stan van Keulen +9 more

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Science(2017)10.1126/science.aan6733

N/A

1.3DataRank · unranked

6550 citations

Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh +46 more

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4004

N/A

0.464DataRank · unranked

21 citations

Noah Graham, Paul J. Catalano, Halla Nimeiri, George A. Fisher, Teri A. Longacre +15 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0.396DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in—A trial of the ECOG-ACRIN Cancer Research Group (EA2174).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4064

N/A

0.396DataRank · unranked

13 citations

Michelle Weitz, Paul J. Catalano, Michael K. Gibson, Lakshmi Rajdev, Onkar V. Khullar +15 more

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial

The Oncologist(2023)10.1093/oncolo/oyad096

N/A

0.276DataRank · unranked

5 citations

Paul Catalano, Steven J. Cohen, Barbara Burtness, Edith Mitchell, Efrat Dotan +7 more

Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysis

Radiotherapy and Oncology(2025)10.1016/j.radonc.2025.110884

N/A

0.208DataRank · unranked

3 citations

Eleanor Brown, George A. Fisher, Andrew Shelton, T.P. Johnson, Shagufta Shaheen +18 more

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad143

N/A

0.165DataRank · unranked

2 citations

Rebecca C. Auer, May Cho, N.A. Dasari, Cynthia Davies-Venn, Cathy Eng +36 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0.104DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4020

N/A

0DataRank · unranked

13 citations

Paul J. Catalano, George A. Fisher, Daniel B. Rubin, Andrei Iagaru, David S. Klimstra +11 more

EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4162

N/A

0DataRank · unranked

3 citations

Noah Graham, Lakshmi Rajdev, Michael K. Gibson, George A. Fisher, Steven H. Lin +3 more

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008339

N/A

0DataRank · unranked

53 citations

Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W. Dulken +25 more

Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit

JCI Insight(2020)10.1172/jci.insight.136570

N/A

0DataRank · unranked

91 citations

Yuming Jiang, Guoxin Li, George A. Fisher, Ruijiang Li, Bailiang Li

Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation

JACC CardioOncology(2022)10.1016/j.jaccao.2022.04.007

N/A

0DataRank · unranked

17 citations

Gerald J. Berry, Ronald Witteles, Dung T. Le, Sean M. Wu, George A. Fisher +2 more

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3978

N/A

0DataRank · unranked

152 citations

Todd S. Crocenzi, Jennifer N. Durham, Elizabeth A. Sugar, Annie A. Wu, Beth Onners +16 more

Complete remission in a patient with widely metastatic HER2-amplified pancreatic adenocarcinoma following multimodal therapy informed by tumor sequencing and organoid profiling

medRxiv(2021)10.1101/2021.12.16.21267326

N/A

0DataRank · unranked

1 citations

Amber R. Smith, Gino Pineda, Michitaka Nakano, Flavia Michelini, S. Peter Goedegebuure +28 more